Apoptosis Assays Market

SKU: DMCD2191 | Last Updated On: Dec 30 2022 | Available Formats

> Apoptosis Assays Market is expected to reach a high CAGR of 9.8% By 2029:

Apoptosis Assays Market is segmented by Product (Instruments, Assay Kits (Caspase assays, DNA Fragmentation Assays, Annexin V and Cell Permeability Assays, Mitochondrial Assays), Reagents, Microplates), By Detection Technology (Flow Cytometry, Cell Imaging, and Microscopy, Spectrophotometry, Others), By Application (Drug Discovery and Development, Clinical and Diagnostic Applications, Stem Cell Research, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.

 

Apoptosis Assays Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.8% during the forecast period (2022-2029).

Apoptosis is an active process characterized by cell shrinkage, nuclear and cytoplasmic condensation, chromatin fragmentation, and phagocytosis of the apoptotic cell. Apoptosis is controlled cell ablation that occurs naturally as it is a part of the cell lifecycle. It is observed through flow cytometry, spectrometry, and various other techniques in research institutes and diagnostic laboratories. Several essays are used to detect apoptosis in cell populations, such as caspase assays, DNA fragmentation assays, cell permeability assays, and mitochondrial assays.

Apoptosis Assays Market - Strategic Insights

Metrics

Details

Market CAGR

 9.8%

Segments Covered

By Product, By Applications, By Detection Technology, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Market Dynamics

The global apoptosis assay market is growing due to factors such as increasing infectious and chronic diseases, rising funding for cancer research, and increasing cell-based research.

The increasing number of cancer cases propels the apoptosis assays global market growth.

Several diseases, such as cancers, autoimmune diseases and neurodegenerative diseases, including Alzheimer's, Huntington's, and ALS, demonstrate either a failure of apoptosis to eliminate harmful cells or the inappropriate activation of apoptosis leading to loss of essential cells. The rising prevalence of cancer is one of the major factors propelling market growth. The WHO statistics indicate that cancer accounts for 10 million deaths in 2020, about 1 in 6 deaths from cancer. Around 70% of deaths from cancer occur in low- and middle-income countries; the most common type of cancer is breast (2.26 million cases in 2020), lung (around 2.21 million cases in 2020), and colon & rectum cancers (1.93 million cases in 2020). Apoptosis is an energy-dependent enzymatic cell suicide process involving caspases' activation. The ability of tumor cells to dodge apoptosis is a prime characteristic of most types of cancer. Apoptosis plays an important role in developmental mechanisms, such as preventing the overgrowth of neuronal cell lineages in the developing brain and regulating interdigital spacing in limb development. Hence, the market for apoptosis assay is growing with the rising prevalence of cancer cases.

The high developmental cost is restraining the global apoptosis assay market growth.
However, the high cost of detection technology and huge capital investments are hindering the growth of the apoptosis assay market.

Industry analysis.

The global apoptosis assays market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing analysis, Etc.

Segment Analysis

The assay kits segment is assumed to command the global market throughout the forecast period (2022-2029).

The assay kits segment dominated the market share in 2021, owing to the repeated consumption of assays in various apoptosis procedures. The assay kits are further segmented into caspase assays, annexin V and cell permeability assays, DNA fragmentation assays, and mitochondrial assays. Manufacturers are innovating new assay kits, which boosts the growth of this segment. For instance, Abbkine launched a TUNEL apoptosis detection kit (orange fluorescence) which provides all the essential components with an optimized assay protocol suitable for fluorescence microplate reader, fluorescence microscopy, or flow cytometer. Also, with the introduction of flow cytometry, scientists can track the apoptotic progression from induction through surface receptors to the end stages of DNA fragmentation, frequently simultaneously.

Geographical Analysis

The North American region holds the largest market share of the global apoptosis assays market.

North America is dominating the global apoptosis assays market, accounting for the largest market share in 2021, owing to the rising prevalence of chronic and infectious diseases, an increasing number of scientific studies conducted across the region, growing support of government bodies in the form of research investments, and the availability of high-quality infrastructure for research & development. For instance, the National Cancer Institute estimated that 1,806,590 new cancer cases were diagnosed in the United States in 2020, and 606,520 people died. Furthermore, the American Cancer Society 2021 estimated that around 1.9 million new cancer cases were diagnosed, and 608,570 deaths were registered under cancer as a death reason for the year 2021. CDC has projected that the number of new cancer cases per year will rise to 29.5 million by 2040. Also, the growing cell-based research and development of apoptosis-modulating drugs and increasing R&D investments by major players and healthcare spending in North America are other factors contributing to this market.

Competitive Landscape

The apoptosis assay market is competitive, with players focusing on developing new drugs to gain a significant market share. Some major players include Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Becton, Dickinson and Company, Bio-Techne Corporation, Promega Corporation, Abcam PLC, and Biotek Instruments, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Apoptosis Assays market globally. For instance, on o3 August 2022, Bio-Rad acquired Curiosity Diagnostics. Also, on 30 August 2021, Danaher Corporation acquired Aldevron.

Thermo Fisher Scientific Inc.

Overview:

Thermo Fisher Scientific Inc. is a U.S.-based company founded in 1956. It is the world leader in serving science with annual revenue of approx. $40 billion has industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Product Portfolio:

 The product portfolio of Thermo Fisher Scientific Inc. for apoptosis assays has TaqMan Array Human Apoptosis Panel, LentiArray Human Apoptosis CRISPR Library, Glycerol, Single-Channel Dead Cell Apoptosis Kit with Annexin V Alexa Fluor 488 and SYTOX Green Dyes, for flow cytometry, Mitochondrial Membrane Potential Apoptosis Kit, Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Etc.

The global apoptosis assays market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Frequently Asked Questions

What is the Projected CAGR value of the Apoptosis Assays Market ?

Apoptosis Assays Market  is expected to grow at a CAGR of 9.8% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Apoptosis Assays Market  during 2022-2029.

Which is the fastest growing region in the Apoptosis Assays Market ?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period.

Trending Topics

Osteoporosis Drugs Market

Actinic Keratosis Treatment Market

Apheresis Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest